InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the complete record of transactions filed by WEINSTEIN ROBERT, Chief Financial Officer. Officer active across 2 companies, notably Synaptogenix, Inc.. Cumulatively, 9 reports have been logged. Total volume traded: €198k. The latest transaction was disclosed on 20 April 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
€43,96445,000 shares@ €0.97722.2% of flow
Common Stock
SEC:0000950138-22-000108:0·
031,250 shares0
Common Stock
SEC:0000950138-22-000034·
031,250 shares0
Common Stock
SEC:0000950138-22-000034:0·
€76,90463,000 shares@ €1.2207100.0% of flow
Common Stock
SEC:0000950138-21-000470·
€76,90463,000 shares@ €1.220738.9% of flow
Common Stock
SEC:0000950138-21-000470:0·
0200,000 shares0
Common Stock
SEC:0000950138-21-000394·
0200,000 shares0
Common Stock
SEC:0000950138-21-000394:0·
060,000 shares0
Common Stock, par value $0.0001 per share
SEC:0001104659-21-092716·
060,000 shares0
Common Stock, par value $0.0001 per share
SEC:0001104659-21-092716:0·
9 of 9 declarations
About WEINSTEIN ROBERT
Robert Weinstein is the Chief Financial Officer and Director of Synaptogenix, Inc. and XpresSpa Group, Inc. In his roles, he oversees financial management, strategic planning, and financial performance analysis for both companies. Robert plays a crucial role in optimizing financial resources and making informed decisions to support growth and profitability. His financial expertise is a valuable asset to the boards of both companies.
